Skip to content
Clinical Trial Events
BIO-Europe 2026

Talk Presenting Companies (Theatre B) track

Drug Discovery and Development: ATB Antivirals Ltd

Mon, Nov 9, 2026 · 3:45–4:00 PM CET Koelnmesse

About this session

ATB Antivirals Oy is a Finland-based biotechnology company developing novel, proprietary antiviral therapies designed to target the underlying viral biology rather than only managing the symptoms or complications of infection. Headquartered in Turku, Finland, the company builds on decades of academic research and expertise in antiviral drug discovery, translational science, and therapeutic development. ATB’s lead program is a novel topical anti-HPV therapy designed to target HPV-infected cells and address the underlying viral drivers of disease.

Speaker